ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
避孕概念
1,240.09
+12.46
1.01%
漲家數:
2
跌家數:
4
平家數:
- -
市盈率:
- -
高:
1,245.24
開:
1,230.10
低:
1,227.11
收:
1,227.63
資料載入中...
總覽
新聞
Veru Inc.盤中異動 臨近收盤股價大跌5.09%
市场透视
·
07-10
強生公司在與Viatris和梯瓦製藥的專利糾紛中勝訴
环球市场播报
·
07-09
曼恩凱德生物醫療盤中異動 早盤急速拉昇5.11%
市场透视
·
07-09
Generation Bio Co.盤中異動 快速拉昇5.27%報0.347美元
市场透视
·
07-08
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4584/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"避孕概念","latestPrice":1240.0898,"timestamp":1753214399999,"preClose":1227.6346,"halted":0,"volume":14136909,"delay":0,"changeRate":0.010146,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":12.4552,"latestTime":"07-22 16:00:00 EDT","open":1230.096,"high":1245.2444,"low":1227.1128,"amount":177954190.678422,"amplitude":0.01477,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1753257600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.136419,"peRate":-14.224514,"turnoverRate":0.008558,"increases":2,"decrements":4,"flats":0,"marketCap":20299800106,"floatMarketCap":20092478864},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":1245.2444,"amplitude":0.01477,"preClose":1227.6346,"low":1227.1128,"pbRate":"3.136419","latestPrice":1240.0898,"volume":14136909,"delay":0,"open":1230.096,"prevYearClose":1682.2216,"prevWeekClose":1208.6007,"prevMonthClose":1256.7808,"prevQuarterClose":1256.7808,"fiveDayClose":1209.7689,"twentyDayClose":1274.0657,"sixtyDayClose":1133.1616,"secType":"PLATE","market":"US","turnoverRate":0.008558,"peRate":-14.224514,"marketCap":20299800106,"floatMarketCap":20092478864,"timestamp":1753214399999,"nameCN":"避孕概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":2,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550668080","title":"Veru Inc.盤中異動 臨近收盤股價大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550668080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550668080?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 03:52","pubTimestamp":1752090777,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日03时52分,Veru Inc.股票出现波动,股价大幅下跌5.09%。截至发稿,该股报0.551美元/股,成交量179.388万股,换手率1.22%,振幅8.28%。Veru Inc.股票所在的生物技术行业中,整体涨幅为1.51%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710035257953c8295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710035257953c8295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4557","BK4183","VERU","BK4584"],"gpt_icon":0},{"id":"2550022656","title":"強生公司在與Viatris和梯瓦製藥的專利糾紛中勝訴","url":"https://stock-news.laohu8.com/highlight/detail?id=2550022656","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550022656?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 22:58","pubTimestamp":1752073080,"startTime":"0","endTime":"0","summary":"美国联邦巡回上诉法院周二裁定,支持强生公司在与Viatris和梯瓦制药关于神经科药物Invega Sustenna的专利纠纷中的立场。 法院认定Viatris和梯瓦制药未能证明Invega Sustenna相关专利创新是显而易见的,这一裁决将阻止两家公司在美国推出该药物的仿制版本。法院综合考虑了梯瓦和Viatris提出的所有反对论点。 强生的Invega系列药物用于治疗成人精神分裂症,2024年在美销售额达31亿美元,同比增长约8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-07-09/doc-infewyzf2415110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BGHQF631.EUR","LU1244550494.USD","LU1023059063.AUD","JNJ","LU1244550221.USD","LU0345770308.USD","BK4504","LU2347655156.SGD","LU0889566641.SGD","LU2592432038.USD","BK4568","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0203347892.USD","LU1280957306.USD","BK4584","LU1196500208.SGD","LU1221951129.SGD","LU0882574055.USD","LU1032955483.USD","LU1244550577.SGD","LU1732800096.USD","LU2112291526.USD","BK4532","LU0098860793.USD","LU1221951046.USD","LU1506573853.SGD","BK4007","LU2129689514.USD","IE00BJT1NW94.SGD","IE0002270589.USD","LU0234570918.USD","IE00BFXG1179.USD","LU1894683348.USD","LU2505996681.GBP","LU1074936037.SGD","LU0289739699.SGD","BK4585","LU1267930813.SGD","LU1061106388.HKD","LU2602419157.SGD","TEVA","LU1066053197.SGD","BK4559","IE00BBT3K403.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","LU0640476718.USD","IE00B3T34201.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2550659640","title":"曼恩凱德生物醫療盤中異動 早盤急速拉昇5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550659640?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 22:53","pubTimestamp":1752072838,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时53分,曼恩凯德生物医疗股票出现异动,股价快速拉升5.11%。截至发稿,该股报3.81美元/股,成交量82.6153万股,换手率0.27%,振幅4.70%。机构评级方面,在所有7家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为1.18%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225358953c4782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225358953c4782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2549428526","title":"Generation Bio Co.盤中異動 快速拉昇5.27%報0.347美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549428526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549428526?lang=zh_tw&edition=fundamental","pubTime":"2025-07-08 23:05","pubTimestamp":1751987125,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日23时05分,Generation Bio Co.股票出现波动,股价急速拉升5.27%。截至发稿,该股报0.347美元/股,成交量12.957万股,换手率0.19%,振幅4.70%。Generation Bio Co.股票所在的生物技术行业中,整体涨幅为1.07%。Generation Bio Co.公司简介:Generation Bio Co 是一家遗传医学公司,专注于创造基因疗法,为患有罕见和未经治疗的疾病的患者提供持久且可重新治疗的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708230525979e792e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708230525979e792e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","GBIO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":24,"code":"91000000","status":"200"}]}}